Camilla Foged

Professor

Member of:

ORCID: 0000-0003-2812-5588

Publication year:

All

171 - 172 out of 172Page size: 10

Sort by: Title

Published
A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522
Rose, F., Erbo Wern, J., Gavins, F., Andersen, P., Follmann, F. & Foged, Camilla, Feb 2018, In: Journal of Controlled Release. 271, p. 88-97 10 p.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4(+) T-cell response
Karlsen, K., Korsholm, K. S., Mortensen, R., Ghiasi, S. M., Andersen, P., Foged, Camilla & Christensen, D., Dec 2014, In: Nanomedicine. 9, 17, p. 2625-38 14 p.
Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...14 15 16 17 18 Next

ID: 1299454

280 downloads
Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration
Research output: Contribution to journal › Journal article › Research › peer-review
Published
255 downloads
Opportunities and Challenges in the Delivery of mRNA-based Vaccines
Research output: Contribution to journal › Review › Research › peer-review
Published
220 downloads
Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design
Research output: Contribution to journal › Journal article › Research › peer-review
Published